WITH digital therapeutics set to become a $18 billion global opportunity by 2027, it’s time for the pharmaceutical industry to make the most of its potential. “Digital Therapeutics” (DTx) are software-based interventions with proven clinical benefits that aim to prevent, manage, or treat medical conditions, often using tools like mobile apps and sensors to drive